BNR
Burning Rock Biotech Ltd
Burning Rock Biotech Ltd (BNR) has 1 SEC Form 4 filing (7 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 2, 2026.
The most active filer is Director Han Yusheng with 7 filings. Insiders have net bought $6.2M over the trailing 6 months. The largest single insider purchase in this window was $2.0M by Director Han Yusheng on Jun 24, 2026.
- Industry:Medical - Diagnostics & Research
- CEO:Yusheng Han
- Employees:674
- HQ:Guangzhou, CN
- IPO:2020-06-12
Insider Buying
$6.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Han YushengFirst filing | Director | Purchase | 24,760 | $216K | Jul 2 | SEC ↗ |
Han YushengFirst filing | Director | Purchase | 210,000 | $1.9M | Jul 2 | SEC ↗ |
Han YushengFirst filing | Director | Purchase | 111,110 | $1000K | Jul 2 | SEC ↗ |
Han YushengFirst filing | Director | Purchase | 104,650 | $780K | Jul 2 | SEC ↗ |
Han YushengFirst filing | Director | Purchase | 5,990 | $45K | Jul 2 | SEC ↗ |
Han YushengFirst filing | Director | Purchase | 250,000 | $2.0M | Jul 2 | SEC ↗ |
Han YushengFirst filing | Director | Purchase | 24,900 | $199K | Jul 2 | SEC ↗ |
Related companies
Burning Rock Biotech Ltd is in the Healthcare sector.